OpenPV Signal Explorer
FAERS disproportionality dashboard
Reaction

Cross Sensitivity Reaction reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 951 reports · 23 co-occurring drugs

As of the last recalculation, Cross Sensitivity Reaction appears in 951 FAERS reports alongside 23 co-occurring drug terms. The strongest observed disproportionality signal is IBUPROFEN CAPSULE (PRR 34.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Ibuprofen Capsule23934.734.7
Ibuprofen Tablet, Film Coated23934.734.7
Ibupfrofen23934.734.7
Ibuprofen Tablets Usp, 200Mg23934.734.7
Ibuprofen Oral23934.734.7
Ibuprofen Capsules 200 Mg23934.734.7
Ibuprofen 200 Mg23934.734.7
Ibuprofen 200Mg23934.734.7
Ketoprofen1728.928.9
Ibuprofen25828.228.2
Phenytoin2021.421.4
Itraconazole917.017.0
Phenobarbital1116.816.8
Zonisamide1014.915.0
Posaconazole Delayed-Release714.014.1
Rifampicin613.113.1
Naproxen Sodium Tablet, Coated711.411.4
Naproxen Sodium, Coated Tablets711.411.4
Naproxen Sodium 220Mg711.411.4
Daptomycin49.59.5
Rocuronium Bromide59.39.3
Olaparib88.48.4
Apalutamide35.65.6

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.